DK123987D0 - N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE - Google Patents

N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE

Info

Publication number
DK123987D0
DK123987D0 DK123987A DK123987A DK123987D0 DK 123987 D0 DK123987 D0 DK 123987D0 DK 123987 A DK123987 A DK 123987A DK 123987 A DK123987 A DK 123987A DK 123987 D0 DK123987 D0 DK 123987D0
Authority
DK
Denmark
Prior art keywords
derivatives
hydroxyphenyl
methylene
preparing
procedure
Prior art date
Application number
DK123987A
Other languages
Danish (da)
Other versions
DK123987A (en
Inventor
Jacques Comarmond
Thomas Purcell
Lydia Zard
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of DK123987D0 publication Critical patent/DK123987D0/en
Publication of DK123987A publication Critical patent/DK123987A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
DK123987A 1986-03-12 1987-03-11 N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE DK123987A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8603489A FR2595695B1 (en) 1986-03-12 1986-03-12 DERIVATIVES OF N - (((HYDROXY-2 PHENYL) (PHENYL) METHYLENE) AMINO-2) ETHYL) ACETAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (2)

Publication Number Publication Date
DK123987D0 true DK123987D0 (en) 1987-03-11
DK123987A DK123987A (en) 1987-09-13

Family

ID=9333030

Family Applications (1)

Application Number Title Priority Date Filing Date
DK123987A DK123987A (en) 1986-03-12 1987-03-11 N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE

Country Status (12)

Country Link
EP (1) EP0239461A1 (en)
JP (1) JPS62230767A (en)
KR (1) KR870008842A (en)
AU (1) AU6991087A (en)
DK (1) DK123987A (en)
FI (1) FI871067A (en)
FR (1) FR2595695B1 (en)
HU (1) HUT43820A (en)
IL (1) IL81858A0 (en)
NO (1) NO870998L (en)
PT (1) PT84452B (en)
ZA (1) ZA871766B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS103091A3 (en) * 1991-04-12 1992-10-14 Ustav Organicke Chemie A Bioch Protected substituted benzhydrylamines as shoulders for the synthesis ofpeptides on solid phase, process of their preparation and use
NZ268292A (en) * 1993-06-21 1997-09-22 Selectide Corp Solid phase peptide synthesis and supports therefor
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
NZ500353A (en) 1997-04-14 2002-02-01 Cor Therapeutics Inc Cyclic diaza compounds that are selective inhibitors of factor Xa
WO1998046628A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
NZ500352A (en) 1997-04-14 2001-10-26 Cor Therapeutics Inc Cyclic diaza selective factor Xa inhibitors
US6211183B1 (en) * 1997-04-14 2001-04-03 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
EP1611116A2 (en) * 2003-04-08 2006-01-04 Neuromed Technologies, Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2319338A1 (en) * 1975-08-01 1977-02-25 Synthelabo NEW A-PHENYL BENZYLIDENIC DERIVATIVES OF AMINO ACIDS, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM
FR2516509B1 (en) * 1981-11-18 1985-07-26 Synthelabo BENZYLIDENIC DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
HUT43820A (en) 1987-12-28
PT84452B (en) 1989-03-17
AU6991087A (en) 1987-09-17
FR2595695A1 (en) 1987-09-18
IL81858A0 (en) 1987-10-20
FR2595695B1 (en) 1988-12-02
NO870998L (en) 1987-09-14
EP0239461A1 (en) 1987-09-30
DK123987A (en) 1987-09-13
ZA871766B (en) 1987-09-01
PT84452A (en) 1987-04-01
JPS62230767A (en) 1987-10-09
FI871067A0 (en) 1987-03-11
NO870998D0 (en) 1987-03-11
KR870008842A (en) 1987-10-21
FI871067A (en) 1987-09-13

Similar Documents

Publication Publication Date Title
DK163991C (en) DICHLORANILIN DERIVATIVES, PROCEDURE FOR PREPARING THESE, AND PHARMACEUTICAL PREPARATIONS CONTAINING THE DERIVATIVES
DK654589D0 (en) HETEROCYCLIC DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES
TR24840A (en) PROCEDURE AND DEVICE FOR THE IDENTIFICATION OF ERRORS
DK510384A (en) PHARMACEUTICAL PREPARATION FOR INTRAVENOES INJECTION AND PROCEDURE FOR PREPARING THEREOF
DK28787A (en) THIENO-1,4-DIAZEPINE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
DK219387A (en) AMINOTHIAZOL AND AMINOOXAZOLD DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK514688D0 (en) HETEROCYCLIC PEPTIDYL COMPOUNDS, PROCEDURES FOR THE PREPARATION OF THEM, AND THE USE OF THESE
DK123987D0 (en) N- (2-HYDROXYPHENYL) METHYLENE 2-AMINOETHYL ACETAMIDE DERIVATIVES, PROCEDURE FOR PREPARING SUCH DERIVATIVES, AND MEDICINAL CONTAINING THESE
DK343388D0 (en) 2,2-DIMETHYLCHROMAN-3-OL DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF PHARMACEUTICAL AGENTS
DK542584D0 (en) 1,3-DIHYDRO-6-VINYL-7-HYDROXY-FURO- (3,4-C) PYRIDINE DERIVATIVES, PROCEDURE FOR PREPARING THESE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK545684A (en) 1,3-DIHYDRO-6-METHYL-FURO- (3,4-C) -PYRIDINE DERIVATIVES, PROCEDURE FOR PREPARING THESE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK49289A (en) MEDICINAL CONTAINING LACTAMES, SUBSTITUTED LACTAMES CONCERNED, AND PROCEDURES FOR PREPARING THEM
NO891151D0 (en) ARYLPIPERAZINYLALCOXY DERIVATIVES OF CYCLIC IMIDES, AND PROCEDURES FOR PREPARING THEREOF.
DK642588D0 (en) INDANDER DERIVATIVES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK486789D0 (en) BENZOXAZOLINON DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK346889A (en) HETEROPOLYSACCHARID BM07, PROCEDURE FOR PREPARING THEREOF AND USING THEREOF
DK342187D0 (en) 4-PYRIDINE DERIVATIVES, PROCEDURE FOR THE PREPARATION OF SUCH DERIVATIVES, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK114189A (en) BENZOCYCLOHEPTENDER DERIVATIVES, AND MEDICINAL PRODUCTS CONTAINING SUCH COMPOUNDS
DK479889D0 (en) SULFATED OLIGOSACCHARIDES AND DERIVATIVES THEREOF, AND PROCEDURE FOR THE PREPARATION OF SAME
DK553689D0 (en) PHENYLOXYPROPANOLAMINE DERIVATIVES, PROCEDURE FOR PREPARING SUCH COMPOUNDS, AND MEDICINAL CONTAINING THESE
DK115289D0 (en) TRICYCLIC AMINE DERIVATIVES, PROCEDURES FOR PREPARING THEM, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK538089D0 (en) Hitherto unknown TYLOSIN DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK268889D0 (en) CYCLIC D-CYS6 PEPTID RELATIONS, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL AGENTS CONTAINING THESE
DE3879349D1 (en) N- (L-ASPARTYL) AMINO ALCOHOL DERIVATIVES AND SWEETENERS CONTAINING THEM.
DK379287A (en) 1,3-PROPANDIAMINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment